BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21572580)

  • 1. Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study.
    Gould MK; Schultz EM; Wagner TH; Xu X; Ghaus SJ; Wallace RB; Provenzale D; Au DH
    J Thorac Oncol; 2011 May; 6(5):875-83. PubMed ID: 21572580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomography reduce the need for invasive procedures?
    Metin M; Citak N; Sayar A; Pekcolaklar A; Melek H; Kök A; Gurses A
    J Thorac Oncol; 2011 Oct; 6(10):1713-9. PubMed ID: 21716145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
    Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
    J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.
    Chiu CH; Yeh YC; Lin KH; Wu YC; Lee YC; Chou TY; Tsai CM
    J Thorac Oncol; 2011 Oct; 6(10):1697-703. PubMed ID: 21869716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
    Raghunathan R; Cease K; Troeschel S; Zhao L; Gross M; Chen G; Chopra V; Ramnath N
    Am J Clin Oncol; 2018 May; 41(5):513-518. PubMed ID: 27322696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial.
    van't Westeinde SC; de Koning HJ; Thunnissen FB; Oudkerk M; Groen HJ; Lammers JW; Weenink C; Vernhout R; Nackaerts K; Mali W; van Klaveren RJ
    J Thorac Oncol; 2011 Oct; 6(10):1704-12. PubMed ID: 21876458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour metabolic activity measured by fluorodeoxyglucose positron emission tomography for radiotherapy planning as a prognostic factor for locally advanced non-small cell lung cancer.
    Masarykova A; Scepanovic D; Povinec P; Bires P; Lederleitner D; Pobijakova M
    Bratisl Lek Listy; 2018; 119(3):133-138. PubMed ID: 29536740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography.
    Farjah F; Lou F; Sima C; Rusch VW; Rizk NP
    J Thorac Oncol; 2013 Sep; 8(9):1170-80. PubMed ID: 23945387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node staging.
    Rogasch JM; Apostolova I; Steffen IG; Steinkrüger FL; Genseke P; Riedel S; Wertzel H; Achenbach HJ; Kalinski T; Schultz M; Schreiber J; Amthauer H; Furth C
    Eur J Radiol; 2016 Aug; 85(8):1345-50. PubMed ID: 27423672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome analysis of (18)F-fluorodeoxyglucose positron-emission tomography in patients with lung cancer after partial volume correction.
    Ohtaka K; Hida Y; Kaga K; Okamoto S; Shiga T; Tamaki N; Muto J; Nakada-Kubota R; Hirano S; Matsui Y
    Anticancer Res; 2013 Nov; 33(11):5193-8. PubMed ID: 24222169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations Between PET Textural Features and GLUT1 Expression, and the Prognostic Significance of Textural Features in Lung Adenocarcinoma.
    Koh YW; Park SY; Hyun SH; Lee SJ
    Anticancer Res; 2018 Feb; 38(2):1067-1071. PubMed ID: 29374742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity in [18F]fluorodeoxyglucose positron emission tomography/computed tomography of non-small cell lung carcinoma and its relationship to metabolic parameters and pathologic staging.
    van Gómez López O; García Vicente AM; Honguero Martínez AF; Soriano Castrejón AM; Jiménez Londoño GA; Udias JM; León Atance P
    Mol Imaging; 2014; 13():. PubMed ID: 25248853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
    Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer.
    Saydam O; Gokce M; Kilicgun A; Tanriverdi O
    Med Oncol; 2012 Jun; 29(2):589-94. PubMed ID: 21380783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features.
    van Loon J; Siedschlag C; Stroom J; Blauwgeers H; van Suylen RJ; Knegjens J; Rossi M; van Baardwijk A; Boersma L; Klomp H; Vogel W; Burgers S; Gilhuijs K
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):448-56. PubMed ID: 20971575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
    Pyka T; Bundschuh RA; Andratschke N; Mayer B; Specht HM; Papp L; Zsótér N; Essler M
    Radiat Oncol; 2015 Apr; 10():100. PubMed ID: 25900186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer.
    Kozak MM; Murphy JD; Schipper ML; Donington JS; Zhou L; Whyte RI; Shrager JB; Hoang CD; Bazan J; Maxim PG; Graves EE; Diehn M; Hara WY; Quon A; Le QT; Wakelee HA; Loo BW
    J Thorac Oncol; 2011 May; 6(5):920-6. PubMed ID: 21774104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value of
    Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
    Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
    Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.